Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-000270
Filing Date
2025-01-15
Accepted
2025-01-15 16:18:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 11559
  Complete submission text file 0001950047-25-000270.txt   13045
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Subject) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-19731 | Film No.: 25533132
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Dickinson Andrew D (Reporting) CIK: 0001310204 (see all company filings)

Type: 144